CoChat

Efficacy and Safety of Oral Antidiabetic Drugs in Comparison to Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis

Open access
Poolsup, Nalinee, Suksomboon, Naeti, Amin, Muhammad · 2014 · PLoS ONE

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To assess the efficacy and safety of oral antidiabetic drugs (OADs) in gestational diabetes mellitus (GDM) in comparison to insulin. METHODS: A meta-analysis of randomized controlled trials was conducted. The efficacy and safety of OADs in comparison to insulin in GDM patients were explored. Studies were identified by conducting a literature search using the electronic databases of Medline, CENTRAL, CINAHL, LILACS, Scopus and Web of Science in addition to conducting hand search of relevant journals from inception until October 2013. RESULTS: Thirteen studies involving 2,151 patients met the inclusion criteria. These studies were randomized controlled trials of metformin and glyburide in comparison to insulin therapy. Our results indicated a significant increase in the risk for preterm births (RR, 1.51; 95% CI, 1.04-2.19, p = 0.03) with metformin compared to insulin. However, a significant decrease in the risk for gestational hypertension (RR, 0.54; 95% CI, 0.31-0.91, p = 0.02) was found. Postprandial glucose levels also decreased significantly in patients receiving metformin (MD, -2.47 mg/dL; 95% CI, -4.00, -0.94, p = 0.002). There was no significant difference between the two groups for the remaining outcomes. There were significant increases in the risks of macrosomia (RR, 2.34; 95% CI, 1.18-4.63, p = 0.03) and neonatal hypoglycemia (RR, 2.06; 95% CI, 1.27-3.34, p = 0.005) in the glyburide group compared to insulin whereas results for the other analyzed outcomes remained non-significant. CONCLUSION: The available evidence suggests favorable effects of metformin in treating GDM patients. Metformin seems to be an efficacious alternative to insulin and a better choice than glyburide especially those with mild form of disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0109985

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow chart of article selection.
Figure 1 Flow chart of article selection.CC BY · PubMed Central
Figure 2 Risk of bias graph of studies comparing metformin to insulin.
Figure 2 Risk of bias graph of studies comparing metformin to insulin.CC BY · PubMed Central
Figure 3 Risk of bias summary of studies comparing metformin to insulin.
Figure 3 Risk of bias summary of studies comparing metformin to insulin.CC BY · PubMed Central
Figure 4 Risk of bias graph of studies comparing glyburide to insulin.
Figure 4 Risk of bias graph of studies comparing glyburide to insulin.CC BY · PubMed Central
Figure 5 Risk of bias summary of studies comparing glyburide to insulin.
Figure 5 Risk of bias summary of studies comparing glyburide to insulin.CC BY · PubMed Central
Figure 6 Neonatal outcomes comparing metformin and insulin.
Figure 6 Neonatal outcomes comparing metformin and insulin.CC BY · PubMed Central
Figure 7 Maternal outcomes comparing metformin and insulin.
Figure 7 Maternal outcomes comparing metformin and insulin.CC BY · PubMed Central
Figure 8 Neonatal outcomes comparing glyburide and insulin.
Figure 8 Neonatal outcomes comparing glyburide and insulin.CC BY · PubMed Central
Figure 9 Maternal outcomes comparing glyburide and insulin.
Figure 9 Maternal outcomes comparing glyburide and insulin.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. 2013, Gestational diabetes mellitus: Clinical management guidelines for obstetricians–gynecologists, Obstet Gynecol, 122, 406

Cited by

See all 107

Metadata

Authors
Poolsup, N., Suksomboon, N., & Amin, M.
Affiliations
  • Silpakorn University (TH)
  • Mahidol University (TH)
Corresponding author
Suksomboon, Naeti
Venue
PLoS ONE
Published
2014-10-10
Volume
9
Issue
10
Pages
e109985
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2041276822
Cited by
107
References
49
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 15 · 2022: 8 · 2021: 30 · 2020: 4 · 2019: 9 · 2018: 14 · 2017: 9 · 2016: 5 · 2015: 7
FWCI
1.12
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Greater South Information System
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
gestational diabetes mellitus, oral antidiabetic drugs, metformin, glibenclamide, insulin therapy, preterm birth, gestational hypertension, macrosomia, neonatal hypoglycemia, postprandial blood glucose, drug safety
MeSH terms
Female, Glyburide, Humans, Hypoglycemic Agents, Insulin, Metformin, Pregnancy, Diabetes, Gestational, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and Safety of Oral Antidiabetic Drugs in Comparison to Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0109985
The paper
Poolsup, N., Suksomboon, N., & Amin, M. (2014). Efficacy and Safety of Oral Antidiabetic Drugs in Comparison to Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis. PLoS ONE. https://doi.org/10.1371/journal.pone.0109985

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.